Mostrar el registro sencillo del ítem
Exercise as an adjuvant therapy against chronic atrial fibrillation
dc.contributor.author | Santos-Lozano A. | |
dc.contributor.author | Sanchis-Gomar F. | |
dc.contributor.author | Barrero-Santalla S. | |
dc.contributor.author | Pareja-Galeano H. | |
dc.contributor.author | Cristi-Montero C. | |
dc.contributor.author | Sanz-Ayan P. | |
dc.contributor.author | Garatachea N. | |
dc.contributor.author | Fiuza-Luces C. | |
dc.contributor.author | Lucia A. | |
dc.date.accessioned | 2020-09-02T22:28:06Z | |
dc.date.available | 2020-09-02T22:28:06Z | |
dc.date.issued | 2016 | |
dc.identifier | 10.1016/j.ijcard.2016.01.140 | |
dc.identifier.citation | 207, , 180-184 | |
dc.identifier.issn | 01675273 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/6199 | |
dc.description | [No abstract available] | |
dc.language.iso | en | |
dc.publisher | Elsevier Ireland Ltd | |
dc.subject | Arrhythmias | |
dc.subject | Atrial fibrillation | |
dc.subject | Cardiovascular disease | |
dc.subject | Exercise | |
dc.subject | angiotensin receptor antagonist | |
dc.subject | anticoagulant agent | |
dc.subject | beta adrenergic receptor blocking agent | |
dc.subject | calcium antagonist | |
dc.subject | digoxin | |
dc.subject | dipeptidyl carboxypeptidase inhibitor | |
dc.subject | diuretic agent | |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | |
dc.subject | warfarin | |
dc.subject | adjuvant therapy | |
dc.subject | Article | |
dc.subject | cardiovascular parameters | |
dc.subject | chronic atrial fibrillation | |
dc.subject | coronary artery disease | |
dc.subject | disease association | |
dc.subject | disease classification | |
dc.subject | disease duration | |
dc.subject | exercise | |
dc.subject | heart disease | |
dc.subject | heart failure | |
dc.subject | human | |
dc.subject | hypertension | |
dc.subject | ischemic heart disease | |
dc.subject | outcome assessment | |
dc.subject | oxygen consumption | |
dc.subject | priority journal | |
dc.subject | quality of life | |
dc.subject | systematic review | |
dc.subject | therapy effect | |
dc.subject | treatment duration | |
dc.subject | treatment response | |
dc.subject | atrial fibrillation | |
dc.subject | case control study | |
dc.subject | multimodality cancer therapy | |
dc.subject | procedures | |
dc.subject | prospective study | |
dc.subject | randomized controlled trial (topic) | |
dc.subject | Atrial Fibrillation | |
dc.subject | Case-Control Studies | |
dc.subject | Combined Modality Therapy | |
dc.subject | Exercise | |
dc.subject | Humans | |
dc.subject | Prospective Studies | |
dc.subject | Randomized Controlled Trials as Topic | |
dc.title | Exercise as an adjuvant therapy against chronic atrial fibrillation | |
dc.type | Article |